These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32883524)

  • 1. Cooperation of G12/13 and Gi proteins via lysophosphatidic acid receptor-2 (LPA
    Minami K; Ueda N; Ishimoto K; Kurisu R; Takamoto M; Ikeda H; Tsujiuchi T
    Biochem Biophys Res Commun; 2020 Nov; 532(3):427-432. PubMed ID: 32883524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysophosphatidic acid receptor-2 (LPA
    Minami K; Ueda N; Ishimoto K; Tsujiuchi T
    Mol Cell Biochem; 2020 Jun; 469(1-2):89-95. PubMed ID: 32301060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced cellular functions through induction of LPA
    Takahashi K; Fukushima K; Fukushima N; Honoki K; Tsujiuchi T
    Mol Cell Biochem; 2017 Jul; 431(1-2):29-35. PubMed ID: 28205098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysophosphatidic acid receptor-2 (LPA
    Takahashi K; Minami K; Otagaki S; Ishimoto K; Fukushima K; Fukushima N; Honoki K; Tsujiuchi T
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2698-2703. PubMed ID: 30093116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of lysophosphatidic acid (LPA) receptor-2 (LPA
    Ueda N; Minami K; Ishimoto K; Tsujiuchi T
    Cell Signal; 2020 May; 69():109551. PubMed ID: 32006610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of chemoresistance by lysophosphatidic acid (LPA) signaling through LPA
    Minami K; Ueda N; Maeda H; Ishimoto K; Otagaki S; Tsujiuchi T
    Biochem Biophys Res Commun; 2019 Sep; 517(2):359-363. PubMed ID: 31362892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different effects of lysophosphatidic acid receptor-2 (LPA
    Ishimoto K; Minami A; Minami K; Ueda N; Tsujiuchi T
    J Recept Signal Transduct Res; 2021 Feb; 41(1):93-98. PubMed ID: 32672083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LPA1 receptors mediate stimulation, whereas LPA2 receptors mediate inhibition, of migration of pancreatic cancer cells in response to lysophosphatidic acid and malignant ascites.
    Komachi M; Tomura H; Malchinkhuu E; Tobo M; Mogi C; Yamada T; Kimura T; Kuwabara A; Ohta H; Im DS; Kurose H; Takeyoshi I; Sato K; Okajima F
    Carcinogenesis; 2009 Mar; 30(3):457-65. PubMed ID: 19129242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The MLK-related kinase (MRK) is a novel RhoC effector that mediates lysophosphatidic acid (LPA)-stimulated tumor cell invasion.
    Korkina O; Dong Z; Marullo A; Warshaw G; Symons M; Ruggieri R
    J Biol Chem; 2013 Feb; 288(8):5364-73. PubMed ID: 23319595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of cellular responses to X-ray irradiation through the activation of lysophosphatidic acid (LPA) receptor-3 (LPA
    Ikeda H; Takai M; Yashiro N; Amano Y; Hara K; Yamamoto M; Tsujiuchi T
    Pathol Res Pract; 2024 May; 257():155293. PubMed ID: 38615508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysophosphatidylethanolamine utilizes LPA(1) and CD97 in MDA-MB-231 breast cancer cells.
    Park SJ; Lee KP; Kang S; Chung HY; Bae YS; Okajima F; Im DS
    Cell Signal; 2013 Nov; 25(11):2147-54. PubMed ID: 23838008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of LPA signaling via LPA receptor-2 in the promotion of malignant properties in osteosarcoma cells.
    Takahashi K; Fukushima K; Tanaka K; Minami K; Ishimoto K; Otagaki S; Fukushima N; Honoki K; Tsujiuchi T
    Exp Cell Res; 2018 Aug; 369(2):316-324. PubMed ID: 29859140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The G12/13-RhoA signaling pathway contributes to efficient lysophosphatidic acid-stimulated cell migration.
    Bian D; Mahanivong C; Yu J; Frisch SM; Pan ZK; Ye RD; Huang S
    Oncogene; 2006 Apr; 25(15):2234-44. PubMed ID: 16301993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysophosphatidic acid signaling via LPA
    Fukushima K; Takahashi K; Yamasaki E; Onishi Y; Fukushima N; Honoki K; Tsujiuchi T
    Exp Cell Res; 2017 Mar; 352(1):139-145. PubMed ID: 28189636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LPA(4)/GPR23 is a lysophosphatidic acid (LPA) receptor utilizing G(s)-, G(q)/G(i)-mediated calcium signaling and G(12/13)-mediated Rho activation.
    Lee CW; Rivera R; Dubin AE; Chun J
    J Biol Chem; 2007 Feb; 282(7):4310-4317. PubMed ID: 17166850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A lysophosphatidic acid receptor lacking the PDZ-binding domain is constitutively active and stimulates cell proliferation.
    Shano S; Hatanaka K; Ninose S; Moriyama R; Tsujiuchi T; Fukushima N
    Biochim Biophys Acta; 2008 May; 1783(5):748-59. PubMed ID: 18157949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LPA2 (EDG4) mediates Rho-dependent chemotaxis with lower efficacy than LPA1 (EDG2) in breast carcinoma cells.
    Chen M; Towers LN; O'Connor KL
    Am J Physiol Cell Physiol; 2007 May; 292(5):C1927-33. PubMed ID: 17496233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative effects of G-protein-coupled free fatty acid receptor GPR40 on cell migration and invasion in fibrosarcoma HT1080 cells.
    Ishii S; Kitamura Y; Hirane M; Tomimatsu A; Fukushima K; Takahashi K; Fukushima N; Honoki K; Tsujiuchi T
    Mol Carcinog; 2016 Nov; 55(11):1553-1559. PubMed ID: 26331585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of lysophosphatidic acid (LPA) signaling via LPA receptors on cellular functions associated with ATP reduction in osteosarcoma cells treated with ethidium bromide.
    Kurisu R; Takamoto M; Minami K; Ueda N; Yamada M; Shima N; Otani T; Sakai Y; Kondo D; Tsujiuchi T
    J Bioenerg Biomembr; 2022 Apr; 54(2):109-117. PubMed ID: 35260987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LPA
    Minami K; Ueda N; Ishimoto K; Tsujiuchi T
    Exp Cell Res; 2020 Mar; 388(1):111813. PubMed ID: 31904382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.